The in vivo inhibition of collagen synthesis and the reduction of prolyl hydroxylase activity by 3,4-dehydroproline.
D000818:Animals; D002614:Chelating Agents / Q000494:pharmacology; D003094:Collagen / Q000096:biosynthesis*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D007501:Iron / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D009928:Organ Specificity; D011393:Procollagen-Proline Dioxygenase / Q000378:metabolism*; D011392:Proline / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D014599:Uterus / Q000187:drug effects / Q000378:metabolism*
D002614:Chelating Agents; D004958:Estradiol; D003094:Collagen; D003577:Cytochrome P-450 Enzyme System; D011392:Proline; D007501:Iron; D011393:Procollagen-Proline Dioxygenase